Activation and control of pathogenic T cells in OSP/claudin-11-induced EAE in SJL/J mice are dominated by their focused recognition of a single epitopic residue (OSP58M)

International Immunology

Volumn 20, Issue 11, 2008, Pages 1439-1449

  Kaushansky, Nathali ^a   Eisenstein, Miriam ^a   Oved, Joseph H ^a   Ben Nun, Avraham ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Autoimmunity; B cells; Neuroimmunology; T cells

Indexed keywords

ALANINE; CLAUDIN 11; EPITOPE; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE PROTEIN; MYELIN PROTEIN; OLIGODENDROCYTE SPECIFIC PROTEIN 55 80; OLIGODENDROCYTE SPECIFIC PROTEIN 58M; PEPTIDE DERIVATIVE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CELL SPECIFICITY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; IMMUNOREGULATION; MOUSE; NONHUMAN; OLIGODENDROGLIA; OPTIC NEURITIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

AMINO ACID MOTIFS; ANIMALS; AUTOANTIGENS; CELL LINE; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNE TOLERANCE; IMMUNIZATION; LYMPHOCYTE ACTIVATION; MICE; MODELS, MOLECULAR; MULTIPLE SCLEROSIS; NERVE TISSUE PROTEINS; PEPTIDES; PROTEIN BINDING; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTES;

EID: 54949136164     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxn099     Document Type: Article

References (39)

1. Stevens, D. B., Chen, K., Seitz, R. S., Sercarz, E. E. and Bronstein, J. M. 1999. Oligodendrocyte-specific protein peptides induce experimental autoimmune encephalomyelitis in SJL/J mice. J. Immunol. 162:7501.
2. Zhong, M. C., Cohen, L., Meshorer, A., Kerlero de Rosbo, N. and Ben-Nun, A. 2000. T-cells specific for soluble recombinant oligodendrocyte-specific protein induce severe clinical experimental autoimmune encephalomyelitis in H-2(b) and H-2(s) mice. J. Neuroimmunol. 105:39.
3. Vu, T., Myers, L. W., Ellison, G. W., Mendoza, F. and Bronstein, J. M. 2001. T-cell responses to oligodendrocyte-specific protein in multiple sclerosis. J. Neurosci. Res. 66:506.
4. Bronstein, J. M., Popper, P., Micevych, P. E. and Farber, D. B. 1996. Isolation and characterization of a novel oligodendrocytespecific protein. Neurology 47:772.
5. Bronstein, J. M., Micevych, P. E. and Chen, K. 1997. Oligodendrocyte- specific protein (OSP) is a major component of CNS myelin. J. Neurosci. Res. 50:713.
6. Babbe, H., Roers, A., Waisman, A. et al. 2000. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192:393.
7. Morita, K., Sasaki, H., Fujimoto, K., Furuse, M. and Tsukita, S. 1999. Claudin-11/OSP-based tight junctions of myelin sheaths in brain and Sertoli cells in testis. J. Cell Biol. 145:579.
8. Gow, A., Southwood, C. M., Li, J. S. et al. 1999. CNS myelin and sertoli cell tight junction strands are absent in OSP/claudin-11 null mice. Cell 99:649.
9. Chow, E., Mottahedeh, J., Prins, M., Ridder, W., Nusinowitz, S. and Bronstein, J. M. 2005. Disrupted compaction of CNS myelin in an OSP/ Claudin-11 and PLP/DM20 double knockout mouse. Mol. Cell. Neurosci. 29:405.
10. Morris-Downes, M. M., McCormack, K., Baker, D., Sivaprasad, D., Natkunarajah, J. and Amor, S. 2002. Encephalitogenic and immunogenic potential of myelin-associated glycoprotein (MAG), oligodendrocyte-specific glycoprotein (OSP) and 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) in ABH and SJL mice. J. Neuroimmunol. 122:20.
11. Kaushansky, N., Zhong, M. C., Kerlero de Rosbo, N., Hoeftberger, R., Lassmann, H. and Ben-Nun, A. 2006. Epitope specificity of autoreactive T and B cells associated with experimental autoimmune encephalomyelitis and optic neuritis induced by oligodendrocyte-specific protein in SJL/J mice. J. Immunol. 177:7364.
12. Bronstein, J. M., Lallone, R. L., Seitz, R. S., Ellison, G. W. and Myers, L. W. 1999. A humoral response to oligodendrocytespecific protein in MS: A potential molecular mimic. Neurology 53:154.
13. Kaushansky, N., Hemo, R., Eisenstein, M. and Ben-Nun, A. 2007. OSP/ claudin-11-induced EAE in mice is mediated by pathogenic T cells primarily governed by OSP192Y residue of major encephalitogenic region OSP179-207. Eur. J. Immunol. 37:2018.
14. Ben-Nun, A. and Lando, Z. 1983. Detection of autoimmune cells proliferating to myelin basic protein and selection of T cell lines that mediate experimental autoimmune encephalomyelitis (EAE) in mice. J. Immunol. 130:1205.
15. Mendel, I., Kerlero de Rosbo, N. and Ben-Nun, A. 1995. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: Fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur. J. Immunol. 25:1951.
16. Fremont, D. H., Monnaie, D., Nelson, C. A., Hendrickson, W. A. and Unanue, E. R. 1998. Crystal structure of I-Ak in complex with a dominant epitope of lysozyme. Immunity 8:305.
17. de Rosbo, N. K., Kaye, J. F., Eisenstein, M. et al. 2004. The myelin-associated oligodendrocytic basic protein region MOBP15-36 encompasses the immunodominant major encephalitogenic epitope(s) for SJL/ J mice and predicted epitope(s) for multiple sclerosis-associated HLA-DRB1*1501. J. Immunol. 173:1426.
18. Ben-Nun, A., Kerlero de Rosbo, N., Kaushansky, N. et al. 2006. Anatomy of T cell autoimmunity to myelin oligodendrocyte glycoprotein (MOG): Prime role of MOG44F in selection and control of MOG-reactive T cells in H-2b mice. Eur. J. Immunol. 36:478.
19. Reizis, B., Eisenstein, M., Mor, F. and Cohen, I. R. 1998. The peptide-binding strategy of the MHC class II I-A molecules. Immunol. Today 19:212.
20. Kalbus, M., Fleckenstein, B. T., Offenhausser, M. et al. 2001. Ligand motif of the autoimmune disease-associated mouse MHC class II molecule H2-A(s). Eur. J. Immunol. 31:551.
21. Bankovich, A. J., Girvin, A. T., Moesta, A. K. and Garcia, K. C. 2004. Peptide register shifting within the MHC groove: Theory becomes reality. Mol. Immunol. 40:1033.
22. Greer, J. M., Sobel, R. A., Sette, A., Southwood, S., Lees, M. B. and Kuchroo, V. K. 1996. Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein. J. Immunol. 156:371.
23. Windhagen, A., Scholz, C., Hollsberg, P., Fukaura, H., Sette, A. and Hafler, D. A. 1995. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity 2:373.
24. Racke, M. K., Bonomo, A., Scott, D. E. et al. 1994. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180:1961.
25. Street, N. E. and Mosmann, T. R. 1991. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J. 5:171.
26. Evavold, B. D. and Allen, P. M. 1991. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 252:1308.
27. Sloan-Lancaster, J. and Allen, P. M. 1995. Signalling events in the anergy induction of T helper 1 cells. Ciba Found. Symp. 195:189. discussion 196.
28. Sloan-Lancaster, J. and Allen, P. M. 1996. Altered peptide ligand-induced partial T cell activation: Molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 14:1.
29. Aruna, B. V., Ben-David, H., Sela, M. and Mozes, E. 2006. A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas-FasL-mediated apoptosis. Immunology 118:413.
30. Ben-David, H., Sela, M. and Mozes, E. 2005. Down-regulation of myasthenogenic T cell responses by a dual altered peptide ligand via CD4+CD25+-regulated events leading to apoptosis. Proc. Natl Acad. Sci. USA 102:2028.
31. Paas-Rozner, M., Sela, M. and Mozes, E. 2003. A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25- and CTLA-4-expressing CD4+ T cells. Proc. Natl Acad. Sci. USA 100:6676.
32. Sakaguchi, S. and Sakaguchi, N. 2005. Regulatory T cells in immunologic self-tolerance and autoimmune disease. Int. Rev. Immunol. 24:211.
33. Shevach, E. M., Piccirillo, C. A., Thornton, A. M. and McHugh, R. S. 2003. Control of T cell activation by CD4+CD25+ suppressor T cells. Novartis Found. Symp. 252:24; discussion 36-44, 106.
34. Wraith, D. C., Nicolson, K. S. and Whitey, N. T. 2004. Regulatory CD4+ T cells and the control of autoimmune disease. Curr. Opin. Immunol. 16:695.
35. Alleva, D. G., Gaur, A., Jin, L. et al. 2002. Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide. Diabetes 51:2126.
36. Bronstein, J. M., Tiwari-Woodruff, S., Buznikov, A. G. and Stevens, D. B. 2000. Involvement of OSP/claudin-11 in oligodendrocyte membrane interactions: Role in biology and disease. J. Neurosci. Res. 59:706.
37. Bruno, R., Sabater, L., Sospedra, M. et al. 2002. Multiple sclerosis candidate autoantigens except myelin oligodendrocyte glycoprotein are transcribed in human thymus. Eur. J. Immunol. 32:2737.
38. Delarasse, C., Daubas, P., Mars, L. T. et al. 2003. Myelin/ oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice. J. Clin. Invest. 112:544.
39. Kaushansky, N., Zilkha-Falb, R., Hemo, R. et al. 2007. Pathogenic T cells in MOBP-induced murine EAE are predominantly focused to recognition of MOBP21F and MOBP27P epitopic residues. Eur. J. Immunol. 37:3281.